Core Insights - Scott Galloway defines being "rich" as having passive income that exceeds expenses, suggesting that financial freedom is a more accurate measure of wealth than income alone [1][2] Group 1: Definition of Wealth - Galloway's father earns approximately $52,000 annually from various sources, including a pension and rental income, while spending $48,000, illustrating the concept of wealth through passive income [2] - Galloway argues that many high-income individuals may not be truly wealthy if their lifestyles exceed their income [1] Group 2: Steps to Financial Freedom - Galloway proposes a three-step process to achieve financial freedom, emphasizing the importance of focus [3] - He criticizes the trend of side hustles, suggesting that individuals should concentrate on excelling in their primary job to become top performers in their field [4] - Galloway highlights the significance of understanding controllable factors in wealth management, such as spending and investing in low-cost ETFs and index funds [5]

The central bank announced the measures in mid-November, allowing banks and non-banking finance companies to offer exporters a moratorium on loan repayments and restructuring options to ease stress from delayed receivables and extended working capital cycles. The scheme, which ends on December 31, was aimed at preventing defaults amid global trade uncertainties and tariff-related disruptions.Banks have urged RBI to extend the scheme by one more quarter, citing continued challenges for exporters from supply ...

Sensient’s earnings momentum looks solid, but one concentrated investor just made a very different call about where future upside really lies.New York City-based Rivermont Capital Management cut its holding in Sensient Technologies Corporation (SXT +0.17%), reducing its stake by 205,939 shares, a value change of $20.65 million, according to a November 13 SEC filing.What HappenedAccording to a Form 13-F filed with the Securities and Exchange Commission (SEC) on November 13, Rivermont Capital Management sold ...

Core Viewpoint - A class action lawsuit has been filed against SLM Corporation (Sallie Mae) for alleged violations of the Securities Exchange Act of 1934, with a focus on misleading statements regarding delinquency rates in private education loans [1][3]. Group 1: Lawsuit Details - The class action lawsuit, titled Zappia v. SLM Corporation, allows investors who suffered losses between July 25, 2025, and August 14, 2025, to seek appointment as lead plaintiff by February 17, 2026 [1]. - The lawsuit alleges that SLM and its executives made false statements about the company's financial health, particularly regarding early stage delinquencies in private education loans [3][4]. Group 2: Allegations and Impact - The lawsuit claims that SLM experienced a significant increase in early stage delinquencies, contradicting previous assurances from the company's CFO about normal seasonal trends [3][4]. - A report from investment bank TD Cowen indicated that July 2025 delinquencies rose by 49 basis points month-over-month, which was worse than the expected seasonal increase of 10 basis points [4]. - Following the release of this report, SLM's stock price fell by approximately 8%, highlighting the market's reaction to the alleged misstatements [4]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who invested in SLM securities during the class period to seek lead plaintiff status, which involves directing the lawsuit on behalf of all class members [5]. - The lead plaintiff can choose a law firm to represent the class, and participation as lead plaintiff does not affect an investor's ability to share in any potential recovery [5]. Group 4: Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has been recognized for its significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [6].

LOS ANGELES--(BUSINESS WIRE)---- $MCTA--MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm. ...

Author's note: I present and update my best small-cap Busted IPO stock ideas only to subscribers of my exclusive marketplace, The Busted IPO Forum . Try a free 2-week trial today by clicking HERE .Shares of ultrasound device concern Butterfly Network, Inc. ( BFLY ) have doubled since announcing the launch of Compass AI, aimed at improving workflows on November 17, 2025. The company's novel approach to its handheld, single-probe, full-body ultrasound leverages semiconductors as opposed toThe Busted IPO Forum ...

Amazon - Amazon has deployed over 1 million robots in its warehouses, projected to save up to $4 billion annually in fulfillment costs, with expectations of significantly lifting operating margins for the retail segment by 2030 [1] - The company is investing heavily in AI, with planned capital expenditures projected at $125 billion in 2025, focusing on custom silicon chips to enhance performance and reduce costs compared to competitors [2] - Amazon's advertising segment is the fastest-growing, with annualized revenue expected to exceed $60 billion in 2025, potentially approaching $100 billion annually in the coming years [3] - Amazon Web Services (AWS) remains the primary profit engine, accounting for approximately 30% of the global cloud infrastructure market [4] - In Q3 2025, Amazon reported revenue of $180.2 billion, a 13% year-over-year increase, with net income rising 38% to $21.2 billion [7] Vertex Pharmaceuticals - Vertex Pharmaceuticals has a trailing-10-year return of around 90%, driven by its cystic fibrosis drug franchise and expansion into the rare disease market [8] - The company is diversifying its portfolio with late-stage clinical programs targeting kidney disease, pain management, and type 1 diabetes, supported by a solid balance sheet and substantial free cash flow [9] - Vertex is launching Casgevy, a gene-editing therapy for sickle cell disease, and Journavx, a non-opioid medicine for pain management, with significant market interest and regulatory approvals [10][11] - The company reported revenue of over $3 billion in Q3 2025, an 11% increase from the previous year, and is positioned for significant growth through innovation and diversification [14] TJX Companies - TJX Companies has seen a nearly 150% increase in stock value over the last five years, attributed to its effective off-price retail model [15] - The company plans to expand its store footprint to 7,000 globally, enhancing its physical presence in existing and new markets [16] - TJX's business model encourages frequent shopper visits due to its ever-changing inventory and unique product offerings, appealing to cost-conscious consumers [17] - In Q3 2026, TJX reported earnings per share of $1.28 on $15.1 billion in revenue, reflecting year-over-year increases of 12% and 7% respectively [19]

Oil is closing 2025 as one of the negative-performing assets. Despite starting the year with a rally, oil's movement soon became typical bear-market dynamics. Consistent price decline interrupted by volatile, sharp double-digit rallies.Still, even in that environment, oil majors saw significant performance discrepancies. ConocoPhillips (NYSE:COP) lost 8.3% year-to-date, while Exxon Mobil (NYSE:XOM) squeezed a double-digit gain of over 11%.Going into 2026, oil has become one of the most consensus-bearish ass ...

Core Insights - Chart Industries leverages expertise in cryogenic and heat transfer technologies to support energy transition initiatives and industrial efficiency, positioning itself as a key partner in rapidly evolving markets [1] Financial Performance - The company generates revenue through capital equipment sales, process technology, aftermarket services, and equipment leasing, with a diversified offering across four business segments [2] - As of the latest report, Chart Industries shares were priced at $205.85, reflecting a 5% increase over the past year, underperforming the S&P 500, which rose approximately 15% in the same period [2] Investment Activity - Absolute Gestao de Investimentos disclosed a new position in Chart Industries, acquiring 440,746 shares valued at $88.22 million as of September 30, indicating significant investment interest [3] - The fund's allocation of roughly 11% of its reported U.S. equity assets to Chart Industries signals strong conviction in the company's fundamentals [4] Operational Highlights - In the third quarter, Chart Industries experienced a nearly 44% year-over-year increase in orders, reaching a record $1.68 billion, with total backlog exceeding $6 billion [5] - Demand is driven by sectors such as LNG, data centers, hydrogen, carbon capture, and industrial gas, with customers committing capital years in advance [5] - Despite GAAP losses related to merger and termination costs, adjusted operating margins improved to approximately 23%, indicating strong underlying earnings potential [5] Strategic Fit - The investment in Chart Industries aligns with broader themes of global growth and emerging markets, as the company's equipment addresses energy security, electrification, and decarbonization [6]

Group 1 - The core viewpoint of the traders is a macro shift that will pressure the US dollar, with a cautious outlook for 2026 [3][7] - The stock market has seen upward momentum in 2025, largely driven by AI, but skepticism remains regarding its sustainability [3][4] - The traders are focusing on gold as a key investment, predicting its continued growth as the US dollar's status declines [4][5] Group 2 - Danny Moses emphasizes that gold is a critical indicator of economic stability and expects its price to rise alongside a weakened US dollar [5][6] - Vincent Daniel anticipates the continuation of the debasement trade in 2026, suggesting it will outperform the S&P despite potential volatility [6]